Clinical Trial Update: A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression [Phase 2]

View source ↗

Summary

Phase 2 home-based trial of BI 1358894 for depression was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder

Drugs mentioned

• BI-1358894

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Depressive Disorder, Major | Phase 2 | Status: TERMINATED | Results posted: 2023-05-11